AMH and PCOS/PMOS: What This Hormone Actually Means

You get your bloodwork back, and one number is flagged as exceptionally high: your AMH. Your doctor might have mentioned that this stands for anti-Müllerian hormone, or perhaps they smiled and told you it means you have "a high ovarian reserve" or "the ovaries of a twenty-year-old."

But if you are dealing with irregular periods, jawline acne, thinning hair, or months at a time without ovulating, that high number is not a cheerful fertility metric. It is a direct window into why your ovaries are stuck.

Polycystic ovary syndrome (PCOS) — also called PMOS in recent medical literature — is the condition this article walks through. In PCOS, a sky-high AMH level tells a very specific story about your biology. It explains why your follicles are stalling, why your testosterone is elevated, and why your cycle has gone missing. Crucially, the high number does not mean what most women are told it means: it is not a sign of exceptional ovarian reserve. It is a sign of follicle arrest, which is something quite different.

Here is exactly what AMH is, why it spikes in PCOS, what the number on your lab report actually means for your fertility, and what you can do to get your endocrine system moving again.

What exactly is anti-Müllerian hormone (AMH)?

To understand why AMH matters in PCOS, you first have to look at how a healthy menstrual cycle operates.

Every month, your brain sends a signal called follicle-stimulating hormone (FSH) to your ovaries. This signal tells a small group of dormant, immature follicles — the tiny fluid-filled sacs that hold your eggs — to wake up and start growing. As those follicles begin to develop, the cells lining them produce anti-Müllerian hormone (AMH — a hormone made by your follicles).

The specific cells that secrete AMH are called granulosa cells. They sit on the inside wall of each developing follicle, and the amount of AMH they release depends almost entirely on how many small follicles you have actively growing at any given moment. In a balanced cycle, AMH acts as a biological gatekeeper. It prevents your ovaries from waking up too many follicles at once. As the days pass, one follicle becomes dominant. It matures, releases an egg during ovulation, and the remaining smaller follicles dissolve. Because only a controlled number of follicles are growing at a time, the amount of AMH released into your bloodstream stays relatively low and stable across your cycle.

But in PCOS, this orderly process is disrupted by a breakdown in communication between your brain and your ovaries.

Why are AMH levels so high in PCOS?

The clinical presentation of PCOS — irregular cycles, excess androgens, and missed ovulation — is driven by a reinforcing loop between your brain, your ovaries, and your metabolism.

The disruption begins centrally. The part of your brain that paces hormone signals to your ovaries starts firing too rapidly. This rapid pulsing drives up the secretion of luteinizing hormone (LH) while keeping FSH relatively low (McCartney & Campbell 2020). The elevated LH acts directly on the cells in your ovaries that produce androgens, pushing them to overproduce testosterone. The excess local testosterone physically slows the development of your follicles.

Because your FSH levels are not strong enough to push a single follicle all the way to maturity, the follicles start to grow but then abruptly stall. They arrest in a state of suspended animation — not dead, not maturing, just paused. Because ovulation fails to occur, these small, arrested follicles do not dissolve. Instead, they accumulate along the edge of the ovary month after month.

This is where the AMH spike comes from. Because you now have dozens of these tiny, stalled follicles sitting in your ovaries, their granulosa cells collectively pump out massive amounts of anti-Müllerian hormone. In PCOS, AMH levels are typically two to three times higher than normal reference ranges. The elevation is driven both by the increased number of small follicles and by an increased production of AMH per follicle, which is further stimulated by the high androgen environment (Diamanti-Kandarakis & Dunaif 2012).

The high number on your blood test is not a sign of "super fertility." It is a direct measurement of the biological traffic jam happening inside your ovaries.

High AMH does not mean high ovarian reserve

This is the single most common misreading of AMH lab results in PCOS, and it is worth pausing on.

In women without PCOS, AMH is broadly proportional to the size of the ovarian reserve — the pool of remaining eggs in the ovaries. A higher AMH suggests more eggs in waiting; a low AMH in a 38-year-old without PCOS suggests her egg supply is declining ahead of schedule. This is the framing most general practitioners learned in medical school, and it is why so many women with PCOS leave their appointment thinking their high AMH is essentially good news.

In PCOS, the proportionality breaks. Your AMH is not high because you have an unusually large reserve of mature, healthy eggs. It is high because you have a large number of small follicles that started growing and then stalled. Those follicles are stuck in an arrested state, not lining up for ovulation. The eggs inside them are present, but the cellular machinery is not getting them to maturity.

A useful way to think about it: in a healthy ovary, AMH measures how many follicles are queued up to be called. In PCOS, AMH measures how many follicles are stuck in the queue. The number is high in both cases, but the underlying biology is opposite.

This distinction matters for two practical reasons. First, women with PCOS sometimes assume the high AMH means they have all the time in the world to start a family. The reproductive biology is more complicated than that — PCOS is consistently linked to lower live-birth rates per cycle and to higher rates of pregnancy complications when conception does occur. Second, fertility clinics interpreting AMH in isolation can over-stimulate the ovaries during IVF protocols in PCOS patients, raising the risk of ovarian hyperstimulation syndrome. The number means something different in your body than it means in a non-PCOS body.

Can an AMH blood test diagnose PCOS?

For decades, the standard way to diagnose this condition was to perform a transvaginal ultrasound. Doctors would look at the ovaries, see the accumulation of stalled follicles, and label them as "cysts" — a misnomer that lent the syndrome its old name. The ovaries in PCOS do not typically contain true pathological cysts; they contain an accumulation of small, arrested follicles (Adams et al. 1986).

Recognizing that this condition is a systemic metabolic issue rather than a localized gynecological one, a 2026 global consensus formally renamed the condition to polyendocrine metabolic ovarian syndrome (PMOS) (Teede et al. 2026). You can read more about that rename in the guide to what the PMOS name change means for women.

Alongside the name change, the way the condition is diagnosed has evolved. Because those stalled follicles secrete so much AMH, researchers realized the hormone could be measured directly in your blood instead of relying solely on an ultrasound image. The 2023 international evidence-based guideline officially added AMH as a diagnostic tool for adult women (Teede et al. 2023). Clinical data shows that a serum AMH threshold above 35 pmol/L (or roughly 5 ng/mL) is highly sensitive and specific for defining the multifollicular ovaries characteristic of the syndrome (Dewailly et al. 2011).

Under the current Rotterdam criteria — carried forward unchanged into the 2023 international PMOS guideline — an adult woman receives a PCOS diagnosis if she meets two of three features: clinical or biochemical signs of androgen excess (such as jawline acne, unwanted facial hair, or elevated testosterone on bloodwork); irregular or absent menstrual cycles; and polycystic ovaries on ultrasound or elevated AMH. Today, if you are an adult woman presenting with irregular periods and androgen-driven symptoms, a simple AMH blood test can confirm the ovarian aspect of your diagnosis without an invasive ultrasound. The guidelines specify that a patient should be tested via ultrasound or AMH, but not both — using both inflates the false-positive rate.

Why isn't AMH used to diagnose teenagers?

While AMH is a useful diagnostic tool for adult women, the clinical guidelines strictly prohibit using it — or ultrasound — to diagnose adolescents. This restriction is one of the most important refinements in the 2023 international PCOS guideline (Teede et al. 2023).

The reason comes down to normal human development. During puberty and the teenage years, the signaling network between your brain and your ovaries is still maturing. It is entirely biologically normal for a healthy adolescent to have irregular cycles, multifollicular ovaries on ultrasound, and consequently very high AMH levels. Those high adolescent AMH values do not predict PCOS — they reflect a system in the middle of calibration.

If clinicians used AMH or ultrasound on adolescents, they would severely overdiagnose PCOS in young women whose reproductive systems were simply going through a normal developmental phase. For an adolescent to be accurately diagnosed, she must present with both a clear, persistent pattern of irregular cycles and undeniable clinical signs of excess androgens — severe acne, hirsutism, or both — independent of her AMH level.

This is also why an adolescent who was once told she "had PCOS" based on an ultrasound at sixteen often turns out, on reassessment in her twenties, to not have it at all. The diagnosis should not have been made on imaging or AMH alone in the first place.

Does a high AMH mean my hormones are imbalanced?

A high AMH rarely exists in a vacuum. It is almost always a symptom of a broader, systemic endocrine disruption.

When your AMH is elevated, it indicates that your ovaries are trapped in a high-androgen state. The elevated LH from your brain stimulates the androgen-producing cells in your ovaries to overproduce testosterone. This excess local testosterone physically slows the development of your follicles, causing more of them to stall, which in turn produces more AMH (Goodarzi et al. 2011). The loop self-reinforces.

This is why women with high AMH frequently experience the classic visible signs of androgen excess:

• Inflammatory or cystic acne, particularly along the lower face, jawline, and chin, often flaring in the week before menstruation as progesterone drops.
• Hirsutism — unwanted dark, coarse hair growth on the face, chest, or abdomen.
• Diffuse hair thinning across the scalp.

Underneath these visible symptoms is the deeper metabolic loop. Roughly 70 percent of women with PCOS also have insulin resistance, where the muscle and fat cells stop responding to insulin properly and the pancreas compensates by pumping out significantly more of it (Diamanti-Kandarakis & Dunaif 2012). The high circulating insulin then enhances the LH signal at the ovary — pushing testosterone even higher — and suppresses a protein in your blood that binds up loose testosterone (sex hormone-binding globulin, or SHBG). With more testosterone being produced and less of it being bound, your follicles are battered by androgens, they stall more readily, and your AMH climbs.

If you are looking at your lab results and wondering how your specific symptoms map to this kind of systemic disruption, taking a hormonal imbalance quiz can be a helpful first step. It connects the visible signs your body is giving you with the invisible loops driving them.

How does AMH affect ovulation and fertility?

One of the most frustrating aspects of PCOS is that AMH is not just a passive marker of stalled follicles — it actively makes the problem worse.

When your AMH levels climb two to three times higher than normal, that excess hormone begins to interfere with your cycle directly. High AMH counteracts the FSH signal your brain is sending — the signal that would normally push a single follicle into maturation. It also reduces the activity of aromatase, the enzyme that converts androgens into estrogens. By blocking FSH and suppressing estrogen production, the massive wave of AMH effectively locks the ovary down. Follicles cannot mature because AMH is dampening the signal; because they cannot mature, they stall; because they stall, they produce more AMH; and the next wave of follicles is blocked the same way.

This is why chronic anovulation — missing your period for months at a time — is so common in PCOS. The biological traffic jam has to clear before a follicle can mature and release an egg.

For women trying to conceive, this matters in practical terms. PCOS is one of the most common causes of treatable anovulatory infertility worldwide, and ovulation induction is generally first-line treatment. The current evidence supports letrozole — an oral aromatase inhibitor — as the most effective ovulation-induction medication for PCOS-related infertility, producing higher live-birth rates than the older standard, clomiphene (Legro et al. 2014; Franik et al. 2018). Letrozole works by temporarily lowering estrogen, which prompts your brain to release more FSH, which is finally strong enough to push a follicle past the AMH-induced block.

For deeper coverage of the fertility side, see the guides to PCOS fertility, diet, and supplements and to PCOS pregnancy rates and what shapes them.

Can high AMH be passed down to your daughters?

If you have PCOS, you may wonder whether your hormones can affect your future children. Emerging research suggests that AMH plays a surprisingly direct role in how this condition is inherited.

During pregnancy, maternal hormone levels fluctuate, but women with PCOS often carry their significantly elevated AMH levels into pregnancy. A landmark study demonstrated that maternal AMH excess during pregnancy actually reprograms the neuroendocrine development of the fetus (Tata et al. 2018). When a female fetus is exposed to high levels of AMH in the womb, the development of her brain's hormone-pacing center is shifted. In adulthood, this prenatal exposure manifests as the rapid brain signaling, high LH, and stalled follicles characteristic of PCOS.

In animal models, that adult phenotype can be reversed by treating the offspring with a GnRH antagonist — which suggests the prenatal programming is not destiny, but a set-point shift that interacts with adult hormonal physiology. The finding helps explain why PCOS runs so strongly in families, independent of diet or lifestyle factors. It also reframes pre-conception care for women with PCOS: bringing AMH down through metabolic improvement before pregnancy may have effects that reach beyond the mother.

What about endometrial health and other long-term risks?

The systemic loop that elevates your AMH also has downstream consequences worth flagging, because they shape why treating PCOS matters even when fertility is not the immediate concern.

Chronic anovulation eliminates the regular progesterone surge that would normally halt the proliferation of your uterine lining and trigger a period. Without that cyclic progesterone, the lining is left under continuous estrogen stimulation. Over years, this "unopposed estrogen" pattern raises the risk of endometrial hyperplasia and Type I endometrial cancer (Barry et al. 2014). This is one of the strongest reasons clinicians work to restore some form of regular bleed in women with PCOS, even if pregnancy is not the goal — whether via lifestyle-driven cycle restoration, cyclic progesterone, or a combined oral contraceptive.

The metabolic dimension matters too. PCOS/PMOS roughly quadruples the long-term risk of type 2 diabetes and significantly raises the risk of impaired glucose tolerance and metabolic syndrome (Moran et al. 2010; Randeva et al. 2012). There is also a meaningful mental-health pattern: women with PCOS have roughly a four-fold higher risk of moderate-to-severe depressive symptoms compared to controls, independent of body weight (Cooney et al. 2017). The chronic low-grade inflammation, HPA-axis dysregulation, and visible-symptom burden that drives the high-AMH state also drives the mood symptoms — which is part of why an integrated treatment approach matters.

Could it be something other than PCOS?

Before assuming your high AMH and androgen-excess symptoms confirm PCOS, your clinician should consider a genetic condition that looks almost identical: nonclassic congenital adrenal hyperplasia (NCAH). NCAH is driven by a partial deficiency of the 21-hydroxylase enzyme, which causes the adrenal glands to overproduce androgens via a different pathway than PCOS uses (Carmina et al. 2017). Worldwide, NCAH accounts for roughly 4 percent of hyperandrogenic women — small but meaningful. The differential is made by drawing an early-morning serum 17-hydroxyprogesterone (17-OHP) level; if it is significantly elevated, NCAH is the more likely diagnosis. Asking specifically for that test is reasonable if your clinician has not run it.

How do you lower AMH and balance your hormones naturally?

You cannot lower your AMH directly, nor should you try to. AMH is the symptom — a measurement of the stalled follicles — not the root cause of the syndrome. To bring your AMH down and restore a regular menstrual cycle, you have to treat the metabolic and hormonal engine that is causing the follicles to stall in the first place.

For roughly 70 percent of women with PCOS, that engine is insulin resistance. Lowering insulin is the most direct path to clearing the traffic jam.

Address the insulin amplifier

When your muscle and fat cells stop responding to insulin properly, your pancreas compensates by pumping out significantly more of it just to keep your blood sugar stable. This compensatory insulin surge is disastrous for your ovaries. It directly enhances the LH signal, forcing your ovaries to produce even more testosterone (Diamanti-Kandarakis & Dunaif 2012). Simultaneously, high insulin travels to your liver and suppresses the production of SHBG — the protein responsible for binding up excess testosterone in your blood. With more testosterone being produced and less of it bound, your follicles are battered by androgens, they stall, and your AMH climbs.

Lowering your insulin is the single most effective way to break this loop. The international PCOS guideline names lifestyle modification — 150 to 250 minutes of moderate weekly exercise, with a 5 percent body-weight reduction as an initial target for those carrying excess weight — as first-line treatment (Teede et al. 2018; Teede et al. 2023).

Use the 40:1 inositol ratio

Inositol is a naturally occurring compound that acts as a secondary messenger in your cells, helping them respond to both insulin and FSH. In healthy ovaries, there is a specific physiological balance of two forms — myo-inositol (MI) and D-chiro-inositol (DCI) — maintained at a 40:1 ratio.

In PCOS, high insulin levels accelerate the conversion of MI into DCI within the ovary, creating a localized deficiency of myo-inositol — the exact messenger your follicles need to respond to FSH and mature properly. Supplementing with an evidence-based 40:1 ratio of myo-inositol to D-chiro-inositol has been shown to restore metabolic and hormonal parameters faster than myo-inositol alone, improving insulin sensitivity and helping to restart ovulation (Nordio & Proietti 2012; Unfer et al. 2012). As ovulation resumes and the stalled follicles clear out, AMH levels naturally begin to fall.

Manage your dietary glycemic load

Because insulin is the primary driver of the androgen-AMH loop, how you eat fundamentally dictates how your ovaries function. This does not mean adopting a severely restrictive diet or cutting out all carbohydrates. The focus is managing glycemic load — preventing the sharp spikes in blood sugar that trigger massive insulin surges. Anchor each meal with high-quality protein, fiber-rich complex carbohydrates, and healthy fats, and notice how your hunger pattern, energy, and skin track with that pattern over a few weeks.

For a structured way to transition your diet to support insulin sensitivity without feeling deprived, exploring a 7-day hormone reset can provide the practical, day-by-day framework needed to stabilize your blood sugar and begin lowering your androgen burden. For broader treatment context across the full PCOS picture — diagnosis, diet, and the standard interventions stacked together — see the PCOS diagnosis, diet, and treatment guide. And if you want to understand what is actually happening on ultrasound when "polycystic ovaries" are described, the PCOS cysts guide walks through the difference between true cysts and arrested follicles in more depth.

The bottom line on your AMH results

Seeing a high AMH number on your lab results can be incredibly validating. It is tangible, biochemical proof that your symptoms are not in your head. Your irregular cycles, your breakouts, and your fatigue are the result of a measurable, systemic metabolic loop that has temporarily trapped your ovaries in a stalled state.

But your high AMH is not a measure of an exceptional egg reserve. It is a measure of how many follicles are stuck in the queue. And it is not a permanent sentence. By shifting your focus away from the ovaries themselves and targeting the underlying insulin resistance and androgen excess, you can clear the traffic jam. As you restore your body's sensitivity to insulin and provide your follicles with the signaling support they need, ovulation can return, the stalled follicles can resolve, and your AMH will naturally reflect a healthier, balanced endocrine system.